COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

InnoCare Pharma

Biopharmaceutical company focused on therapies for cancer and autoimmune disease, including targeted small molecules.

TICKER9969.HK

HEADQUARTERSBeijing, China

STAGEApproved

ACTIVE TRIALS26

Therapeutic areas

OncologyAutoimmune

Selected products and programs

orelabrutinibICP-332

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Phase 3 · Recruiting · Plaque Psoriasis Patients

ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

Phase 3 · Recruiting · Atopic Dermatitis

Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed/Refractory Marginal Zone Lymphoma

Phase 3 · Recruiting · Relapsed/Refractory Marginal Zone Lymphoma

Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 3 · Recruiting · DLBCL

Evaluate the Safety and Efficacy of Tafasitamab Combined With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Phase 2 · Recruiting · DLBCL

The Study of ICP-248 in Patients With Mature B-cell Malignancies

Phase 1 · Recruiting · Hematological Malignancies

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier: /companies/innocare-pharma/
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record